Chris Moyses

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis

Timothy M. Cox, Robin Lachmann, C. E. Hollak et al. · The Lancet · 2000 · 744 citations

Medicine, Pharmacology, Pharmacotherapy +4

Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM

Marie‐France Kong, P. King, Ian Macdonald et al. · Diabetologia · 1997 · 131 citations · Full text

Medicine, Endocrinology, Pharmacology +12

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus

B. Nyholm, L. Ørskov, Karen Yde Hove et al. · Metabolism · 1999 · 102 citations

Medicine, Endocrinology, Pharmacology +11

Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue

Orville Kolterman, Alan Gottlieb, Chris Moyses et al. · Diabetes Care · 1995 · 79 citations

Medicine, Endocrinology, Pharmacology +13

Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus.

B. Nyholm, Niels Møller, Claus Højbjerg Gravholt et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 40 citations · Full text

Medicine, Endocrinology, Pharmacology +17